Hint mode is switched on Switch off

Anebulo Pharmaceuticals, ordinary share
ANEB, US0345691036

Add a stock to WL
Choose all Reset all
Anebulo Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Anebulo Pharmaceuticals Inc a clinical-stage biotechnology company developing novel solutions for people suffering from cannabinoid overdose and substance addiction
  • Issuer
  • Full borrower / issuer name
    Anebulo Pharmaceuticals Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    ANEB
  • Placement
    07.05.2021
  • Lock up period
    180
  • Number of papers
    3,000,000
  • Volume of raised funds
    21 mln USD
  • Placement share
    12.89%
  • Final placement price
    7 USD
  • Price change since placement date
    -94.28%
  • By capitalization
    162.86 mln USD

IFRS/US GAAP reports

2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Indicators

News

22/04/2026 Analyst Upgrade Signals Strong Outlook for Chevron (NYSE: CVX) Amidst Market Volatility
12/02/2026 Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates
05/02/2026 Anebulo Pharmaceuticals: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Other Events, Financial Statements And Exhibits
27/01/2026 Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer
13/11/2025 Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates
All organization news

Holders

Industry Leaders

Registration is required to get access.